Question

Difficulty: MediumGynecologic Oncology

A 48-year-old female presents to the gynecology clinic reporting a 3-month history of postcoital bleeding and foul-smelling vaginal discharge. She has not received regular medical care or cancer screening for over a decade. Pelvic examination reveals a 5-centimeter friable, exophytic mass replacing the cervix and extending into the upper third of the vaginal wall. There is nodularity in the bilateral parametria on rectovaginal examination. Arrange the following steps in the correct chronological order for the optimal diagnosis, staging, and definitive management of this patient's condition.

  1. 1Histologic confirmation via direct punch biopsy of the visible lesion
  2. 2Clinical staging utilizing positron emission tomography-computed tomography (PET-CT)
  3. 3External beam radiation therapy with concurrent platinum-based chemotherapy
  4. 4Intracavitary brachytherapy

Answer

The correct sequence of management for locally advanced cervical cancer begins with a direct tissue biopsy of the visible lesion, followed by advanced imaging (PET-CT) for clinical staging. Treatment is then initiated with concurrent chemoradiotherapy, and concludes with targeted intracavitary brachytherapy.
The correct chronological approach to a grossly visible, symptomatic cervical mass involves first obtaining a definitive histologic diagnosis through direct punch biopsy. Once cancer is confirmed, the next mandatory step is comprehensive staging with PET-CT to evaluate the extent of local spread and assess for lymph node involvement. Because clinical examination reveals parametrial and vaginal involvement (indicating locally advanced disease), primary surgical intervention such as a radical hysterectomy is strictly contraindicated due to the inability to achieve clear margins and the high risk of severe morbidity. Instead, the patient must undergo primary concurrent chemoradiation (external beam radiation with cisplatin) to treat the extensive pelvic disease. The final step in the treatment pathway is intracavitary brachytherapy, which provides a highly targeted radiation boost to the remaining central cervical tumor to maximize local control.

Step-by-Step Solution

1
Obtain definitive tissue diagnosis
Direct punch biopsy of the cervical mass confirms invasive squamous cell carcinoma.
Grossly visible lesions must be biopsied directly; cervical cytology is a screening tool that can yield false negatives in the presence of necrotic tumor debris.
2
Determine clinical extent of disease
PET-CT evaluates for lymphatic spread and distant metastases to establish the clinical stage.
Clinical staging dictates the treatment modality. The clinical exam already suggests parametrial and vaginal involvement, which shifts the paradigm away from primary surgery.
3
Initiate primary definitive therapy
Concurrent chemoradiation is administered.
External beam radiation combined with a radiosensitizing agent (cisplatin) effectively treats the primary pelvic tumor bed and sterilizes regional lymph nodes without the severe morbidity of aggressive surgery in advanced disease.
4
Deliver targeted radiation boost
Intracavitary brachytherapy is performed.
Brachytherapy maximizes the radiation dose to the central tumor while utilizing the inverse square law to spare adjacent critical structures like the bladder and rectum.

Key Concept

Diagnostic and therapeutic sequencing for locally advanced cervical carcinoma
Estimated Time:1m 30s
Rate this question